Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluorescein for Lymphatic Mapping in Breast Cancer
NCT01614184Phase 2Withdrawn
- Sponsor
- University of Utah
- Start
- May 2008
- Primary completion
- Jun 2013
01
Overview
Phase 2, open-label, single-arm trial of fluorescein in breast cancer, sponsored by University of Utah. Primary endpoint: Sentinel Lymph node detection at 36 months. Planned start May 2008; status: withdrawn.
02
Drugs
fluorescein
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01614184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01614184.